Anti-cancer

Dasatinib

CAS No. 302962-49-8

A multi-targeted tyrosine kinase inhibitor used in oral oncology formulations for chronic myeloid leukemia and acute lymphoblastic leukemia.

Dasatinib is a second-generation tyrosine kinase inhibitor API manufactured by NovaAcura Biotech under GMP-certified conditions. The company provides full batch documentation and regulatory support to global oncology formulation partners.

Applications & Uses

A multi-targeted tyrosine kinase inhibitor used in oral oncology formulations for chronic myeloid leukemia and acute lymphoblastic leukemia.

Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.

Need This Molecule at Scale?

Get in touch for pricing, lead times and full regulatory documentation.

Get In Touch